Millions of people find their daily lives disrupted by gastro-intestinal disorders. We understand that GI research is vital, as gastrointestinal disorders have a tremendous impact on the quality of life of affected patients and their families. They can also have enormous financial cost.
Java is committed to supporting clinical trials in this area as there is considerable potential to identify new approaches for the prevention, diagnosis and treatment of these diseases. There is also a significant opportunity to make progress by taking research discoveries from the laboratory to the patient’s bedside.
Our 12 years of clinical research experience includes the conduct of gastroenterology studies in Phases II-IV which, together with our connections with worldwide gastroenterology experts, has resulted in highly successful clinical trials in the following areas:
- Peptic Ulcer Disease
- Gastroesophageal Reflux Disease (GERD)
- Irritable Bowel Syndrome (IBS)
- Ulcerative Colitis
- Crohn’s Disease
If you are considering a clinical trial in any of these areas, why not call today and learn about our expertise in this field?